Health Departments Bulletin Index
Following is a list of Medicaid General and Special Bulletin articles (2000-present) that pertain specifically to Health Departments.
For a complete list of articles for all providers (including articles about National Provider Identifier) refer to the Index of All Medicaid Bulletins.
- Agalsidase Beta, 35 mg (Fabrazyme, J3490) - Billing Guidelines, 8/03
- Alefacept, 7.5 mg IV; 15 mg IM (Amevive, J3490) - Billing Guidelines , 8/03
- Arsenic Trioxide, 1mg (Trisenox, J9017) – Billing Guidelines, 1/04
- Billing Health Assessments for Refugees, 10/03
- Billing Instructions for Procedure Code T1002, 12/02
- Bortezomib, 3.5 mg (Velcade, J9999) - Billing Guidelines, 8/03
- Breast and Cervical Cancer Medicaid Procedures, 1/04
- Changes in Drug Rebate Manufacturers:
- Childbirth Education Policy Revision, 8/08
- Clarification for Seminar Attendees, 12/04
- Clarification of the Two-Step Tuberculosis (TB) Test Process and Billing, 12/09
- Code Crosswalk Clarification, 8/03
- Compounded Hydroxyprogesterone Caproate,
- Conversion of Refugee Health Assessment Code, STD Control Treatment Code, and TB Control Treatment Code, 8/02
- CPT Code Conversion, Special Bulletin I, May 2000
- CPT Procedure Code 90761, 9/06
- Diabetes Outpatient Self-Management Training: Supervision Clarification, 4/02
- Dietary Evaluation and Counseling, 1/08
- Dental Program Changes, 10/11
- Dental Seminars, 8/11
- Drugs Added to the Physicians Drug Program Billing Guidelines, 1/08
- Electronic Claims Submission ,11/11
- Factor VIIa (Coagulation Factor, Recombinant) per 1.2 mg (Novoseven, Q0187) – Billing Guidelines, 2/03
- Family Planning Billing Clarification, 12/02
- Family Planning Claims Denials, 9/03
- Frequently Asked Questions, 1/01
- Fulvestrant, 250mg/5ml (Faslodex, J9999) – Billing Guidelines, 2/03
- Health Check Billing Guide 2004, Special Bulletin I, April 2004
- Health Department Seminar Schedule, 4/00
- HIPAA Code Conversion, Special Bulletin IV, August 2002
- Home Visit for Postnatal Assessment and Follow-Up Care When There is No Delivery Code, 9/03
- Hydroxyprogesterone Caproate (Makena, HCPCS Code J3490): Billing Guidelines, 4/11
- Immune Globulin (IgIV, Human, for Intravenous Use, CPT 90283) Coverage Clarification, 9/01
- Immune Globulin Intravenous Injection (J1563, 1 gm and J1564, 10mg) - Billing Guidelines, 9/03
- Implantable Contraceptive Capsules, 5/00
- Injectable Drug Coverage through the Pharmacy and Physician’s Drug Programs, 4/03
- Into the Mouths of Babes: Oral Screening and Fluoride Varnish Program, 5/05
- Intrauterine Devices Billable on the CMS-1500 Claim Form - Reimbursement Rates, 6/04
- Introduction to Medicaid's Uniform Screening Program - A Web-Based System Set for Implementation in October 2007, 5/07
- Leuprolide Acetate Implant, 65mg (Viadur, J9219) – Billing Guidelines, 2/03
- Leuprolide Acetate Injectable (HCPCS Procedures Codes): Change in Billing Guidelines, 10/09
- Lidocaine for Topical Anesthesia and Saline/Water Codes: Billing Guidelines, 12/09
- Makena Billing Guidelines Revised for the Physician's Drug Program , 7/11
- Maternal Outreach Worker Services - Revised Billing Guidelines, 7/04
- Medical Nutrition Therapy Diagnosis Code Clarification, 12/02
- Medication Administration Codes, 5/00
- Medroxyprogesterone Acetate/Estradiol Cypionate, 5 mg/25 mg (Lunelle, HCPCS Code J1056) – Billing Guidelines, 4/03
- Mental Health and Substance Abuse Services Guidelines, Special Bulletin IV, December 2001
- Mirena (Levonorgestrel-Releasing Intrauterine System, Code J7302) Coverage Criteria, 3/02
- NC Health Choice Dental Policy, 10/11
- National Drug Codes:
- Norplant Insertion Kit, 10/00
- Omalizumab (Xolair, J3490) – Billing Guidelines, 1/04
- Omalizumab, 5 mg (Xolair, HCPCS Code J2357): Change in Coverage,
- Oral Contraceptives Provided in Local Health Departments (HCPCS Procedure Code S4993), 5/08
- Outpatient Behavioral Health:
- Outpatient Specialized Therapies
- Addition of V Code Diagnosis for Outpatient Specialized Therapies, 5/03
- Changes to Outpatient Specialized Therapies: 12/08; 10/09; 11/09
- Clarification of Billing Instructions for Outpatient Specialized Therapies, 6/03
- Clarification of First Treatment for Outpatient Specialized Therapies, 9/05
- Correction to V Code Diagnosis for Outpatient Occupational Therapy Services, 7/03
- Documentation Standards, 12/10
- Electronic Submission Process for Prior Authorization Requests, 7/06
- Outpatient Specialized Therapies, 9/09
- Outpatient Specialized Therapies CCNC Pilot Project, 6/05
- Outpatient Specialized Therapies and Independent Practitioners Medical Coverage Policy Revisions, 4/03
- Outpatient Specialized Therapies, Special Bulletin V, September 2002
- Post-Payment Validation, 4/10
- Post-Payment Validation Review “Helpful Hints”, 9/10
- Prior Approval of Outpatient Specialized Therapy Services [Workshop], 8/02
- Prior Approval Process: 4/02; 5/02; 4/03; 11/03; 5/04
- Prior Authorization and Post-Payment Validation, 3/10
- Prior Authorization Process - Update to New Web Site and Submission Process, 10/06
- Prior Authorization Process – Post Payment Validation, 6/07
- Prior Authorization Process - Post-Payment Validation Begins August 2007, 7/07
- Prior Authorization Process: Survey Results, 6/08
- Prior Authorization Process - New Fax Forms, 2/07
- Prior Authorization Process - Web Site Registration, 1/07
- Prior Authorization Process - Implementation Date for Electronic Submission and New Forms, 12/06
- Updates to Outpatient Specialized Therapies Prior Approval Process, 7/05
- Web-based Survey for Prior Authorization Website, 3/08
- Paliperidone Palmitate Exended Release, 1 mg (Invega Sustenna,HCPCS Code J2426): Billing Guidelines, 4/11
- Palonosetron 0.25 mg (Aloxi, J3490) – Billing Guidelines, 1/04
- Pegfilgrastim, 6mg (Neulasta, S0135) – Billing Guidelines, 2/03
- Physical and Occupational Therapy Evaluations, 6/00
- Preadmission Screening and Annual Resident Review (PASAAR) Seminars, 6/06
- Pregnancy Medical Home Project Seminars:
- Progestacert IUD, W5142 Now End-dated , 4/03
- Provision of Psychological Services in Health Departments, 4/02
- Purchasing Drugs for Administration in a Provider's Office, 9/03
- Questions from Health Department Workshops, 9/00
- Rates for New Immunization Codes, 7/05
- Recommended Taxonomy Codes for NPI Mapping, 1/08
- Refugee Health Assessment Billing Guidelines, 10/02
- Reimbursement of Immunization Administration Codes for the Health Check Population, 6/08
- Requesting an Exception to the Legislative Visit Limit, 9/09
- Respiratory Therapy Criteria, 7/03
- Revised Orthodontic Services Clinical Coverage Policy, 8/11
- Revision to Rates for Specific Services, 7/05
- Risperidone (Risperdal Consta, J3490) – Billing Guidelines, 1/04
- Sterilization Consent Forms and Hysterectomy and Abortion Statements, 10/09
- Supervision of Services Performed in Health Departments, 9/00
- TB Control and Treatment Provided in Health Departments – Eligible Health Department Providers, 10/02
- Training for Local Health Departments on Health Check Requirements and Billing:
- Training for Local Health Departments on New Codes, 7/02
- Upcoming June Seminars, 4/07
- Use of Codes Y2351 and Y2041, 6/01
- Use of Codes Y2351 and Y2041 – Correction and Addition to June 2001 Bulletin Article, 8/01
- Varicella-Zoster Immune Globulin, Human, for Intramuscular Use (CPT 90396) - Billing Guidelines, 8/02
- Zemplar (Paracalcitrol, HCPCS Code J2501, 1 mcg Injection) - Billing Guidelines, 10/03
